Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The Dual-Action Advantage of Tirzepatide Tirzepatide represents a breakthrough in weight loss pharmacology because it activates two hormone pathways simultaneously: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide)
These incretin effects explain the initially surprising weight loss observed in the treatment groups of the cardiovascular trials, with subjects taking GLP-1/GIP agonists losing from 3% to 12% of their body weight
L., Macnee, W., Johnston, S., Lu, S
Common side effects may include nausea, insomnia, dry mouth, constipation, and headache
US$ 25.10
US$ 27.34
US$ 20.27
US$ 28.80
